Literature DB >> 2159159

Glycemic control of pain threshold in diabetic and control rats.

J H Lee1, R McCarty.   

Abstract

Pain threshold was assessed via tail flick latency in alloxan-diabetic, streptozotocin-diabetic, BB/W-diabetic, and control laboratory rats. In addition, tail flick latency was determined under conditions of both euglycemia (60-120 mg/dl) and hyperglycemia (greater than 250 mg/dl). Conditions of hyperglycemia resulted in a significant decrease in tail flick latency in both diabetic and control animals. More interestingly, tail flick latency was returned to control values in diabetic rats following normalization of blood glucose levels. It is concluded that elevated blood glucose levels result in a decrease in pain threshold in both diabetic and control rats. In addition, a permanent state of painful symptoms may be avoided in clinical diabetes by improvement of diabetic control.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159159     DOI: 10.1016/0031-9384(90)90135-q

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  4 in total

Review 1.  Animal models of peripheral neuropathies.

Authors:  Ahmet Höke
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

2.  Opiate-mediated inhibition of calcium signaling is decreased in dorsal root ganglion neurons from the diabetic BB/W rat.

Authors:  K E Hall; A A Sima; J W Wiley
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

3.  Reduce Muscle Fibrosis through Exercise via NRG1/ErbB2 Modification in Diabetic Rats.

Authors:  Majid Amani; Masoud Rahmati; Mohammad Fathi; Hasan Ahmadvand
Journal:  J Diabetes Res       Date:  2020-05-13       Impact factor: 4.011

4.  Effects of endurance training on hippocampus DJ-1, cannabinoid receptor type 2 and blood glucose concentration in diabetic rats.

Authors:  Mohammad Kurd; Vahid Valipour Dehnou; Seyed A Tavakoli; Daniel E Gahreman
Journal:  J Diabetes Investig       Date:  2018-06-14       Impact factor: 4.232

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.